1. Association of CYP3A5* 3 and CYP1A1* 2C polymorphism with development of acute myeloid leukemia in Egyptian patients;Abd El Wahab;Asian Pac. J. Cancer Prev.,2017
2. Association of Interleukin 10 (IL-10) Gene Polymorphism (819T> C) with Susceptibility to Acute Myeloid Leukemia: A Meta-Analysis;Ahadi;Iran. J. Public Health,2022
3. Management approach to acute myeloid leukemia leveraging the available resources in view of the latest evidence: consensus of the Saudi society of Blood and marrow transplantation;Alahmari;JCO Global Oncology.,2021
4. Potential Impact of TP53 Gene Polymorphism rs1042522 G> C in Leukemia Patients of Saudi Arabia;Al-Amer;SCOPUS IJPHRD CITATION SCORE.,2019
5. Impact of Genetic Polymorphisms and Biomarkers on the Effectiveness and Toxicity of Treatment of Chronic Myeloid Leukemia and Acute Myeloid Leukemia;Alarcón-Payer;J. Personal. Med.,2022